Pharmacological effects of Ba-Wei-Xi-Lei powder on ulcerative colitis in rats with enema application

American Journal of Chinese Medicine

Volumn 34, Issue 3, 2006, Pages 461-469

  Liu, Duan Yong ^a,b   Zhao, Hai Mei ^b   Zhao, Ning ^c   Xin, Zeng Ping ^b   Lu, Ai Ping ^a,b  

^a National Pharmaceutical Engineering Research Center   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Ba Wei Xi Lei powder; Enema application; Pharmacology; T lymphocyte; TNF alpha; Ulcerative colitis

Indexed keywords

BA WEI XI LEI; CHINESE DRUG; ENEMA; FREUND ADJUVANT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; COLON MUCOSA; CONTROLLED STUDY; DRUG FORMULATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTESTINE ULCER; MALE; MUCOSA INFLAMMATION; NONHUMAN; POWDER; PROTEIN EXPRESSION; RABBIT; RAT; RAT STRAIN; ULCERATIVE COLITIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; DRUGS, CHINESE HERBAL; ENEMA; HERBAL MEDICINE; IMMUNOHISTOCHEMISTRY; MEDICINE, HERBAL; POWDERS; RABBITS; RATS;

EID: 33646680232     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X06003990     Document Type: Article

References (20)

1. Bergmann, O.J., S. Ellermann-Eriksen, S.C. Mogensen and J. Ellegaard. Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: Randomised, double blind, placebo controlled trial. B.M.J. 310: 1169-1172, 1995.
2. Bhan, A.K., E. Mizoguchi and R.N. Smith and A. Mizoguchi. Colitis in transgenic and knockout animal as model of human inflammatory bowel disease. Immunol. Rev. 169: 195-207, 1999.
3. Chourasia, M.K. and S.K. Jain. Polysaccharides for colon targeted drug delivery. Drug Deliv. 2: 129-148, 2004.
4. Ding, W.Q., Y.J. Lin, S.R. Xu and L.P. Qian. Tumor necrosis factor and ulcerative colitis. Chin. Dig. J. 8: 499-500, 2001.
5. Du, L.Y., L. Yue and S. Zong. Experimental study on anti-inflammatory effect and analgesic effect of compound Qingdai granula. J. Chin. Med. Univ. 4: 456-458, 2003.
6. Elson, C.O., R.B. Sartor, G.S. Tennyson and R.H. Riddell. Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344-1367, 1995.
7. Farmer, R.G. "Inflammatory Bowel Disease" in Clinical Gastroenterology, 2nd ed. Lea & Febiger, Philadelphia, 1992, pp. 337-350.
8. Gionchetti, P., F. Rizzello, F. Habal, C. Morselli, C. Amadini, R. Romagnoli and M. Campieri. Standard treatment of ulcerative colitis. Dig. Dis. 21: 157-167, 2003.
9. Ishiguro, Y. Mucosal proinflammarory cytokine production correlates with endoscopic activity of ulcerative colitis. J. Gastroenterol. 34: 66, 1999.
10. Lawrence, C. and E. Adina. Diagnosis of Oral Ulcers. Mount Sinai Journal Medline 11: 5-6, 1998.
11. Lin, W.T. and P. Zhu. Practical Clinical Immunology. Fourth Military Medical University Press, 2003, p. 19.
12. Mosmann, T.R. and S. Sad. The expanding universe of T cell subsets: Th1, Th2 and more. Immunol. Today 3: 138, 1996.
13. Neurath, M.F. Immunotherapy of inflammatory bowel disease: Current concepts and future perspectives. Arch. Immunol. Ther. Exp (Warsz). 48: 81-84, 2000.
14. Powrie, F., M.W. Leach, S. Mauze, S. Menon, L.B. Caddle and R.L. Coffman. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1: 553-562, 1994.
15. Powrie, F., M.W. Leach, S. Mauze, L.B. Caddle and R.L. Coffman. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5: 1461, 1993.
16. Powrie, F. and M.W. Leah. Genetic and spontaneous models of inflammatory bowel disease in rodents: Evidence for abnormalities in mucosal immune regulation. Ther. Immunol. 2: 115-123, 1995.
17. Sollid, L.M., D. Kvale, P. Brandtzaeg, G. Markussen and E. Thorsby. Interferon-enhance expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J. Immunol. 138: 4303-4306, 1987.
18. Siew L.F., A.W. Basit and J.M. Newton. The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems. AAPS. Pharm. Sci. Tech. 3: E22, 2000.
19. Wu, H.G., X. Gong, L.Q. Yao, W. Zhang, Y. Shi, H.R. Liu, Y.J. Gong, L.B. Zhou and Y. Zhu. Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis. World J. Gastroenterol. 5: 682-688, 2004.
20. Zhu, F., J.M. Qian and G.S. Pan. The establishment of enteric inflammatory reaction animal model by cellular immune reaction. Bull. Chin. Acad. Med. Sci. 4: 271-277, 1998.